By Mill Chart
Last update: Nov 8, 2023
Discover RESMED INC (NYSE:RMD)—a stock that our stock screener has recognized as a solid dividend pick with strong fundamentals. NYSE:RMD showcases decent financial health and profitability while providing a sustainable dividend. We'll explore the specifics further.
To gauge a stock's dividend quality, ChartMill utilizes a Dividend Rating ranging from 0 to 10. This comprehensive assessment considers various dividend aspects, including yield, history, growth, and sustainability. NYSE:RMD has achieved a 7 out of 10:
To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NYSE:RMD has earned a 7 out of 10:
ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NYSE:RMD, the assigned 8 is a significant indicator of profitability:
Our Best Dividend screener lists more Best Dividend stocks and is updated daily.
Check the latest full fundamental report of RMD for a complete fundamental analysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
RESMED INC
NYSE:RMD (4/26/2024, 7:13:48 PM)
After market: 218.83 +0.77 (+0.35%)218.06
+34.64 (+18.89%)
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Investors liked the healthcare technology company's latest quarterly update.
ResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss drugs could help diagnosis rates.
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ResMed (NYSE:RMD) just reported results for the third quarter of 2024.ResMed re...
RMD stock results show that ResMed beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top S&P500 gainers and losers in today's after hours session.
Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23%Operating cash flows of $402 million Note: A webcast of...